Hepatitis B Surface Antibody (Anti-HBS)

The Hepatitis B surface antibody test is an essential diagnostic procedure conducted by Hypro Diagnostics to identify antibodies produced by the immune system in response to the surface protein of the Hepatitis B virus. This comprehensive test is vital for screening and diagnosing both acute and chronic infections, as well as assessing acquired immunity resulting from HBV vaccination. Following exposure to the Hepatitis B virus, the body initiates a two-phase antibody response, beginning with the production of IgM antibodies, followed by the lifelong production of IgG antibodies. The test is instrumental in determining past exposure to Hepatitis B, evaluating the success of vaccination efforts, and monitoring the progress of a patient’s recovery during treatment. It is particularly recommended for individuals in close contact with infected persons, those exhibiting symptoms such as jaundice, abdominal pain, and dark urine, individuals undergoing immunosuppressive treatments or chemotherapy, as well as those in high-risk pregnancy situations. Additionally, the test is valuable before surgical procedures and to assess the efficacy of vaccination responses. In essence, the Hepatitis B surface antibody test provided by Hypro Diagnostics plays a pivotal role in safeguarding public health by aiding in early diagnosis, treatment monitoring, and preventive measures.Get reports Within 6 days